Literature DB >> 8660135

Regional differences in expression of osteonectin mRNA after administration of cadmium to rats.

M J Lee1, K Saijoh, E J Nestler, R S Duman, K Sumino.   

Abstract

Osteonectin gene expression in relation to metallothionein mRNA expression was investigated in various tissues from Cd-treated rats. After a single 50 micromol/kg subcutaneous injection of CdCl2, Cd predominantly accumulated in the liver and metallothionein gene expression significantly increased concomitantly with Cd accumulation, but no alteration of osteonectin gene expression was observed. In the kidney and lung, both metallothionein and osteonectin mRNA increased significantly but the elevation of metallothionein mRNA levels (1 h after Cd administration) preceded that of osteonectin (3 h after administration). A significant elevation of osteonectin mRNA levels was also observed in the testis after 3 h, but that of metallothionein mRNA occurred after 6 h. Not only accumulation of Cd but also increments in both osteonectin and metallothionein mRNA were minimal in the brain, but a significant increase in gene expression was observed after 1 h for osteonectin and after 3 h for metallothionein. Since, except in the testis, metallothionein gene expression preceded osteonectin gene expression, the induced metallothionein might transpose Cd and thereby affect its levels immediately, thus reducing the levels of Cd available for accumulation in other tissues. Hence, the osteonectin-Cd interaction might be secondary to the metallothionein-Cd interaction. However, the fact that osteonectin mRNA was predominantly induced by Cd administration in the target tissues of Cd toxicity, such as the lung, kidney and testis, suggests the possible involvement of osteonectin in Cd intoxication/detoxication mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8660135     DOI: 10.1007/s002040050218

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  21 in total

1.  Molecular cloning of cDNA for rat brain metallothionein-II and regulation of its gene expression.

Authors:  K Saijoh; T Kuno; H Shuntoh; C Tanaka; K Sumino
Journal:  Pharmacol Toxicol       Date:  1989-05

2.  Mechanisms of regulation of rat hepatic metallothionein-I and metallothionein-II levels following administration of zinc.

Authors:  L D Lehman-McKeeman; G K Andrews; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1988-01       Impact factor: 4.219

Review 3.  The biology of SPARC, a protein that modulates cell-matrix interactions.

Authors:  T F Lane; E H Sage
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

4.  Osteonectin promoter. DNA sequence analysis and S1 endonuclease site potentially associated with transcriptional control in bone cells.

Authors:  M F Young; D M Findlay; P Dominguez; P D Burbelo; C McQuillan; J B Kopp; P G Robey; J D Termine
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

5.  Studies on the relationship between acute testicular damage and urinary and plasma creatine concentration.

Authors:  J Gray; J K Nicholson; D M Creasy; J A Timbrell
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

6.  Transcriptional regulation of the mouse metallothionein-I gene by heavy metals.

Authors:  D M Durnam; R D Palmiter
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

7.  Diverse forms of stress result in changes in cellular levels of osteonectin/SPARC without altering mRNA levels in osteoligament cells.

Authors:  J J Sauk; K Norris; J M Kerr; M J Somerman; M F Young
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

8.  Molecular analysis of Xenopus laevis SPARC (Secreted Protein, Acidic, Rich in Cysteine). A highly conserved acidic calcium-binding extracellular-matrix protein.

Authors:  S Damjanovski; F Liu; M Ringuette
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

9.  Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid).

Authors:  M E Bolander; M F Young; L W Fisher; Y Yamada; J D Termine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33.

Authors:  A Swaroop; B L Hogan; U Francke
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

View more
  2 in total

1.  Responses of bone to titania-hydroxyapatite composite and nacreous implants: a preliminary comparison by in situ hybridization.

Authors:  H Liao; C Brandsten; C Lundmark; T Wurtz; J Li
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  Whole Genome Pathway Analysis Identifies an Association of Cadmium Response Gene Loss with Copy Number Variation in Mutant p53 Bearing Uterine Endometrial Carcinomas.

Authors:  Joe Ryan Delaney; Dwayne G Stupack
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.